Ulf Smith is an expert in Endocrinology at University of Gothenburg (Sweden). As of July 2026, ScienceLeadR ranks Ulf Smith in the top 1% of experts worldwide for Hyperinsulinism, Insulin Resistance and Glucose Metabolism Disorders. Ulf Smith has authored 470 publications, the most recent in 2025, and is an investigator in 3 clinical trials. SLR score: 1,593 (community average: 125). How the SLR is computed.

LeadR Profile

1 593 ScienceLeadR Reputation 1593
Network Map

Endocrinology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1970 - 2025

Source: PubMed

University of Gothenburg

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 470

Citations

Citations: 41 809 1st author: 44 Last author: 205 Unique author: 43


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Senotherapeutics for metabolic disease and diabetic complications.
PMID 41189469 — insulin, metabolic diseases, internal medicine, aging, cellular senescence, therapeutics, tissues, diabetes complications
J Intern Med20250
Specific FAHFAs predict worsening glucose tolerance in non-diabetic relatives of people with Type 2 diabetes.
PMID 40334782 — diabetes mellitus, fasting, insulin, serum, tissues, diabetes mellitus, type 2, fatty acids
J Lipid Res20250
Physical training reduces cell senescence and associated insulin resistance in skeletal muscle.
PMID 40127780 — exercise, cells, genes, insulin resistance, muscles, insulin, cellular senescence, biopsy, genes, regulator, obesity, muscle, skeletal, sarcopenia
Mol Metab20250
Breast volume in non-obese females is related to breast adipose cell hypertrophy, inflammation, and COX2 expression.
PMID 38967364 — cells, cell size, breast neoplasms, neoplasms, hypertrophy, breast, tissues, adipose tissue
J Plast Surg Hand Surg20241
Altered H3K4me3 profile at the TFAM promoter causes mitochondrial alterations in preadipocytes from first-degree relatives of type 2 diabetics.
PMID 37679776 — risk, adipocytes, dna, mitochondrial, cells, epigenesis, genetic, genes, genome, promoter regions, genetic
Clin Epigenetics20237

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 3

By status:

Completed 3

By type:

Interventional 3

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 2
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 2

LeadR Networks

Main global connection map